Edition:
United Kingdom

Ajanta Pharma Ltd (AJPH.NS)

AJPH.NS on National Stock Exchange of India

974.25INR
15 Feb 2019
Change (% chg)

Rs-9.45 (-0.96%)
Prev Close
Rs983.70
Open
Rs984.00
Day's High
Rs992.95
Day's Low
Rs966.00
Volume
441,647
Avg. Vol
384,012
52-wk High
Rs1,457.75
52-wk Low
Rs895.85

Latest Key Developments (Source: Significant Developments)

India's Ajanta Pharma Dec-Qtr Consol Profit More Than Halves
Wednesday, 30 Jan 2019 

Jan 30 (Reuters) - Ajanta Pharma Ltd ::DEC QUARTER CONSOL NET PROFIT 669 MILLION RUPEES VERSUS PROFIT 1.47 BILLION RUPEES YEAR AGO.DEC QUARTER CONSOL REVENUE FROM OPERATIONS 4.85 BILLION RUPEES VERSUS 5.87 BILLION RUPEES YEAR AGO.  Full Article

Ajanta Pharma Says NCLT Did Not Approve Proposed Scheme Of Co With Gabs Investments
Monday, 10 Sep 2018 

Sept 10 (Reuters) - Ajanta Pharma Ltd ::AJANTA PHARMA -NCLT DID NOT DEEM IT FIT TO APPROVE PROPOSED SCHEME OF CO WITH GABS INVESTMENTS.  Full Article

Ajanta Pharma's Formulation Facility At Dahej Inspected By U.S. FDA
Friday, 27 Jul 2018 

July 27 (Reuters) - Ajanta Pharma Ltd ::SAYS FORMULATION FACILITY AT DAHEJ WAS INSPECTED BY US FDA FROM 23 JULY, 2018 TO 27 JULY, 2018.  Full Article

Ajanta Pharma Says There Is No Action Against Co From Office Of Drug Controller General Of India
Tuesday, 17 Jul 2018 

July 17 (Reuters) - Ajanta Pharma Ltd ::SAYS CLARIFIES ON NEWS ITEM,"DRUG CONTROTTER'S ACTION ON AJANTA PHARMA".SAYS THERE IS NO ACTION AGAINST CO FROM OFFICE OF DRUG CONTROLLER GENERAL OF INDIA."REFUTE ALLEGATIONS" MADE AGAINST COMPANY IN THE NEWS ITEM.  Full Article

Ajanta Pharma Gets Shareholders' Nod For Reappointment Of Yogesh M Agrawal As MD
Friday, 6 Jul 2018 

July 6 (Reuters) - Ajanta Pharma Ltd ::GETS SHAREHOLDERS' NOD FOR REAPPOINTMENT OF YOGESH M AGRAWAL AS MD.GETS SHAREHOLDERS' NOD FOR REAPPOINTMENT OF RAJESH M AGRAWAL AS JOINT MD.  Full Article

Ajanta Pharma's Vice-Chairman​ Purushottam B. Agrawal Resigns
Friday, 15 Dec 2017 

Dec 15 (Reuters) - Ajanta Pharma Ltd ::SAYS ‍ PURUSHOTTAM B. AGRAWAL RESIGNS AS VICE-CHAIRMAN​.  Full Article

India's Ajanta Pharma Sept-qtr consol profit rises marginally
Tuesday, 31 Oct 2017 

Oct 31 (Reuters) - Ajanta Pharma Ltd ::Sept quarter consol net profit 1.32 billion rupees versus 1.31 billion rupees year ago.Sept quarter consol revenue from operations 5.40 billion rupees versus 5.16 billion rupees year ago.  Full Article

India's Ajanta Pharma gets final approval for Entacapone tablets from U.S. FDA
Monday, 4 Sep 2017 

Sept 4 (Reuters) - Ajanta Pharma Ltd :Says received the final approval for Entacapone tablets from US FDA.  Full Article